西安“4+7”集中采购药品 中选药**降幅90%以上

2019-06-10 李政 郑伊琛 陕西传媒网

昨日,记者从陕西省医保局获悉,西安作为国家组织药品集中采购和使用“4+7”试点城市之一,试点工作自今年3月25日启动以来,西安市辖区357家公立医疗机构按照“4+7”试点中选药品价格进行网采,未中选药品同步实行梯度降价。

昨日,记者从陕西省医保局获悉,西安作为国家组织药品集中采购和使用“4+7”试点城市之一,试点工作自今年3月25日启动以来,西安市辖区357家公立医疗机构按照“4+7”试点中选药品价格进行网采,未中选药品同步实行梯度降价。

据了解,截至6月2日,25个中选品种40个品规发生采购,采购总数量2585.37万(片/粒/支),占西安地区标的量的595.05%,采购总金额3450.89万元,中选品种采购总数量和总金额分别占同通用名药品采购总数量和总金额的90.79%和64.78%,采购数量、金额及市场占比均超出预期,有效体现出集中采购所具备的优势。同时,参与“4+7”试点中选药品中选价平均降幅达52%,最高降幅达到90%以上,实现了以市场换量、换价,给患者减轻了负担,为医保基金的安全运行创造了有利条件。

目前,陕西省医保局就“同药不同价”、部分中选药品采购量上升幅度较高、部分公立医疗机构停用未中选药品等问题开展调研,积极研究解决对策,充分发挥省级有关职能部门作用,规范医生诊疗和患者就医行为,防止医疗费用异常增长,维护参保群众正当权益和医保基金安全,确保国家“4+7”集中采购和使用试点在西安落实落地。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814439, encodeId=5dcf1814439ea, content=<a href='/topic/show?id=1df0956e504' target=_blank style='color:#2F92EE;'>#采购药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95675, encryptionId=1df0956e504, topicName=采购药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Mar 18 19:27:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398833, encodeId=ad8e1398833e0, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460128, encodeId=b2651460128d5, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532871, encodeId=e2e215328e1ad, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
    2020-03-18 lfcmxl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814439, encodeId=5dcf1814439ea, content=<a href='/topic/show?id=1df0956e504' target=_blank style='color:#2F92EE;'>#采购药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95675, encryptionId=1df0956e504, topicName=采购药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Mar 18 19:27:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398833, encodeId=ad8e1398833e0, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460128, encodeId=b2651460128d5, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532871, encodeId=e2e215328e1ad, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1814439, encodeId=5dcf1814439ea, content=<a href='/topic/show?id=1df0956e504' target=_blank style='color:#2F92EE;'>#采购药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95675, encryptionId=1df0956e504, topicName=采购药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Mar 18 19:27:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398833, encodeId=ad8e1398833e0, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460128, encodeId=b2651460128d5, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532871, encodeId=e2e215328e1ad, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814439, encodeId=5dcf1814439ea, content=<a href='/topic/show?id=1df0956e504' target=_blank style='color:#2F92EE;'>#采购药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95675, encryptionId=1df0956e504, topicName=采购药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Wed Mar 18 19:27:00 CST 2020, time=2020-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1398833, encodeId=ad8e1398833e0, content=<a href='/topic/show?id=794413168f' target=_blank style='color:#2F92EE;'>#4+7#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1316, encryptionId=794413168f, topicName=4+7)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/D2FD7704B41C9E22364B1E54ABB223BB/100, createdBy=1df22500220, createdName=ms1260584454294838, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460128, encodeId=b2651460128d5, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532871, encodeId=e2e215328e1ad, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Jun 12 02:27:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
    2019-06-12 wolongzxh

相关资讯

又一省宣布跟进4+7

日前,医药政策信息平台“红尘医谷”透露疑似《青海省2019年药品集中采购和实施方案》(以下简称《方案》)。 ▍青海跟进4+7 《方案》显示,青海计划在全省实施集中带量采购。采购目录不仅仅包含4+7中选产品,分为三组:

第二批带量采购或将年中开启

近日,业内流传一个说法,第二轮带量采购有望在今年夏季启动,年底前完成。 由于关于第二批带量采购的政策文件尚未出台,我们无法对其进行详细分析,但对于带量采购后续的政策走向,我们不妨通过研报分析,来从理性的角度做一推测

药品集中采购的底层逻辑:谁将掌控4000家药企的未来方向?

2019年1月1日,国务院办公厅印发了《国家组织药品集中采购和使用试点方案》,明确了带量采购、以量换价、招采合一、保证使用等多项基本原则。到目前为止,第一批4+7试点城市的招标采购结果已经出炉,并且第二批目录据说也已在酝酿之中。 值得注意的是,4+7及此前一些省试点的集中带量采购,取得的最大成就,首先是战略性的、理论上的明辨是非,其次才是具体成果

“4+7”降价新时代 招标君的困惑与未来

开篇先送一个彩蛋:某省正在考虑开展全省GPO(集团采购)工作,目前该工作已经在紧锣密鼓地推进,择日,相关方案将正式下发。

医药行业将进入滞胀通道?!

医药行业接连遭遇三大重磅冲击波,恐将进入滞胀通道。 其一,转为两票制后税务负担沉重,资金流转越来越慢,一些企业返款周期已超过半年,甚至更长时间。国家两次降税,一些企业并未向各级客户传递国家政策,向客户收取的基础税点远远高于国家规定。

4+7,江苏全省跟进?!

又一地,明确跟进4+7带量采购。